-
11. NOVEL BILAYER MUCOADHESIVE PATCHES FOR DELIVERY OF CLOBETASOL-17-PROPIONATE TO THE ORAL MUCOSA TO TREAT ORAL LICHEN PLANUS; AN IN VITRO AND IN VIVO EVALUATION
ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY AND ORAL RADIOLOGY
2018 WOS CO-AUTHOR -
12. ANTIBACTERIAL AND BIOFILM INHIBITION ACTIVITIES OF MELASTOMA MALABATHRICUM STEM BARK EXTRACT AGAINST STREPTOCOCCUS MUTANS
MALAYSIAN JOURNAL OF MICROBIOLOGY
2015 SCOPUS CO-AUTHOR -
13. THE IMPROVEMENT OF IN VIVO MODEL (BALB/C MICE) FOR CERVICAL CARCINOGENESIS USING DIETHYLSTILBESTROL
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
2013 WOS MAIN AUTHOR -
14. DILLENIA SUFFRUTICOSA EXHIBITED ANTIOXIDANT AND CYTOTOXIC ACTIVITY THROUGH INDUCTION OF APOPTOSIS AND G2/M CELL CYCLE ARREST
JOURNAL OF ETHNOPHARMACOLOGY
2013 WOS CO-AUTHOR
ACADEMIC QUALIFICATIONS
- PhD in Dentistry (2019)
- Master in Pharmacology (2011)
- Bachelor in Biomedical Science (2005)
DR. ZULFAHMI BIN SAIDPENSYARAH UNIVERSITI DS13 Faculty Fakulti Pergigian Biography A lecturer from Fakulti Pergigian. Holds a Phd in Dentistry. Usim Expert: https://expert.usim.edu.my/zulfahmi Phone: 03-42892518 E-mail: zulfahmi@usim.edu.my |
RESEARCHER
ID
|
-
1. ELUCIDATING THE ROLE OF ZIRCONIA MICROPARTICLE WASTE IN MODULATING THE PROPERTIES OF PHOTOPOLYMER RESINS FOR 3D-PRINTED DENTAL CROWNS.
2026 GERAN PENYELIDIKAN FUNDAMENTAL ON GOING CO-RESEARCHER -
2. CHARACTERIZATION OF MECHANICAL PROPERTIES AND MICROBIAL ADHERENCE OF HIGH-PERFORMANCE POLYMER, POLYETHERIMIDE (PEI) REINFORCED ON THREE-DIMENSIONAL (3D) PRINTED REMOVABLE DENTURE BASE
2024 GERAN PENYELIDIKAN PUSAT TANGGUNGJAWAB (PTJ) ON GOING CO-RESEARCHER -
3. MECHANISM UNDERLYING WOUND HEALING ACTIVITY OF TUALANG HONEY-SAGO/PVA HYDROGELS.
2024 GERAN KPT ON GOING CO-RESEARCHER -
4. PHYSICOCHEMICAL PROPERTIES OF HEAT CURE DENTURE BASE FABRICATED FROM RECYCLED POLYMETHYL METHACRYLATE (PMMA) RESIN
2023 BIDUNI MIZANNIYAH COMPLETED CO-RESEARCHER -
5. ANTIFUNGAL ACTIVITY OF FIG VINEGAR AGAINST THE ADHERENCE OF CANDIDA ALBICANS ON DENTURES
2021 BIDUNI MIZANNIYAH COMPLETED MAIN RESEARCHER
Completed: 8 (57%)
Ongoing: 6 (43%)